Familial Chylomicronemia Syndrome
📧 Sign up to get email alerts when something new happens for Familial Chylomicronemia Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome [Phase 3]
Phase 3 study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese adults with Familial Chylomicronemia Syndrome has completed, and res…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) [Phase 3]
Phase 3 study results have been posted for ARO-APOC3 (Plozasiran) in adults with Familial chylomicronemia syndrome; the trial is currently a…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) [Phase 3]
Phase 3 clinical trial of ARO-APOC3 (Plozasiran) in adults with Familial Chylomicronemia Syndrome has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects [Phase 1, Phase 2]
RN0361 is being studied in healthy adults and adults with hypertriglyceridemia (including familial chylomicronemia syndrome) in Phase 1 and …
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS) [Phase 1]
Phase 1 study evaluating ARO-APOC3 in healthy volunteers and patients with hypertriglyceridemia or familial chylomicronemia syndrome has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS) [Phase 3]
Phase 3 trial of olezarsen in familial chylomicronemia syndrome has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome [Phase 3]
Phase 3 trial of volanesorsen in familial chylomicronemia syndrome completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome [Phase 3]
Phase 3 open-label study of volanesorsen in familial chylomicronemia syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-07Clinical Trial Update: Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS) [Phase 2]
Phase 2 trial update for AKCEA-ANGPTL3-LRx (ISIS 703802) in Familial Chylomicronemia Syndrome (and related lipoprotein lipase deficiency) ha…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. [Phase 3]
Extension of a Phase 3 randomized, double-blind, placebo-controlled study of LCQ908 in familial chylomicronemia syndrome was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia [Phase 2]
A Phase 2 pilot study evaluating CAT-2003 for familial chylomicronemia syndrome and related lipid disorders has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating LCQ908 in familial chylomicronemia syndrome has completed with resul…
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects [Phase 2, Phase 3]
Completed Phase 2/3 trial evaluating the efficacy and safety of LPL S447X gene therapy expressed by an adeno-associated viral vector in indi…